Find the latest Nevro Corp. (NVRO) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · Globus Medical (GMED, Financials) agreed to acquire Nevro Corp. (NVRO, Financials) in an all-cash transaction valued at approximately $250 million. Warning!

Get the latest Nevro Corp. (NVRO) stock news and headlines to help you in your trading and investing decisions.

Nov 8, 2024 · Nevro Corp (NYSE:NVRO) is set to release its Q3 2024 earnings on Nov 11, 2024. The consensus estimate for Q3 2024 revenue is $93.07 million, and the earnings are expected to come in at -$0.76 per ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

NVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 preliminary results amid a weak SCS market.

NVRO expects fourth-quarter 2024 U.S. revenues to be in the range of $91 million-$92 million, representing a decrease of 9% to 10% compared with the fourth quarter of 2023.

Sep 26, 2024 · Strength in NVRO's Senza Platform and business diversification plans raises optimism about the stock.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced its preliminary, unaudited ...

Aug 9, 2024 · In this article, we are going to take a look at where Nevro Corp. (NYSE:NVRO) stands against Engaged Capital's other top holdings.